Lv71
4760 积分 2021-11-19 加入
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
2小时前
求助中
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
2小时前
已完结
15th Annual University of Pennsylvania conference on statistical issues in clinical trial/advances in time-to-event analyses in clinical trials (afternoon panel discussion)
1个月前
已完结
The Role of Statistical Thinking in Biopharmaceutical Research
1个月前
已完结
Designing cancer screening trials for reduction in late-stage cancer incidence
1个月前
已完结
Designing cancer screening trials for reduction in late-stage cancer incidence
2个月前
已完结
Defining estimands for efficacy assessment in single arm phase 1b or phase 2 clinical trials in oncology early development
3个月前
已完结
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma
4个月前
已完结
Comparative review of novel model‐assisted designs for phase I/II clinical trials
4个月前
已完结
Do You Want to Stay Single? Considerations on Single‐Arm Trials in Drug Development and the Postregulatory Space
5个月前
已完结
皖公网安备34019202002308
